Publications for Birgit Olsson
Co-author map based on ISI articles 2007-

Publications mentioned in social media 1 times*

Keywords

tumors tamoxifen s6k2 radiotherapy pten protein prognostic pik3ca patients p53 livin hsd17b1 hbiot2 gene colon cancer breast benefit amplification 11q13

Journal Articles

Zhen-Yu Ding, Hong Zhang, Gunnar Adell, Birgit Olsson and Xiao-Feng Sun
  Livin expression is an independent factor in rectal cancer patients with or without preoperative radiotherapy
  Radiation Oncology, 2013, 8(281), .
   Fulltext  PDF  
 Web of Science® Times Cited: 1

Zhen-Yu Ding, Gui-Hong Liu, Birgit Olsson and Xiao-Feng Sun
  Upregulation of the antiapoptotic factor Livin contributes to cisplatin resistance in colon cancer cells
  Tumor Biology, 2013, 34(2), 683-693.
   Fulltext  PDF  
 Web of Science® Times Cited: 5

Yang-mei Shen, Gunnar Arbman, Per Sandström, Per Gullstrand, Yu-Quan Wei, Hong Zhang, Johan Rosell, Birgit Olsson, Feng Peng, Han-Shuo Yang, Chun-Ting Wang and Xiao-Feng Sun
  Novel gene hBiot2 is an independent prognostic factor in colorectal cancer patients
  Oncology Reports, 2012, 27(2), 376-382.
 Web of Science® Times Cited: 2

Yang-mei Shen, Gunnar Arbman, Birgit Olsson and Xiao-Feng Sun
  Overexpression of GLUT1 in colorectal cancer is independently associated with poor prognosis
  International Journal of Biological Markers, 2011, 26(3), 166-172.
 Web of Science® Times Cited: 2

Elin Karlsson, Marie Ahnström, Josefine Bostner, Gizeh Perez-Tenorio, Birgit Olsson, Anna-Lotta Hallbeck and Olle Stål
  High-Resolution Genomic Analysis of the 11q13 Amplicon in Breast Cancers Identifies Synergy with 8p12 Amplification, Involving the mTOR Targets S6K2 and 4EBP1
 
Altmetric usage: 1

  Genes, Chromosomes and Cancer, 2011, 50(10), 775-787.
   Fulltext  PDF  
 Web of Science® Times Cited: 12

Gizeh Perez-Tenorio, Elin Karlsson, Marie Ahnström, Birgit Olsson, Birgitta Holmlund, Bo Nordenskjöld, Tommy Fornander, Lambert Skoog and Olle Stål
  Clinical potential of the mTOR targets S6K1 and S6K2 in breast cancer
  Breast Cancer Research and Treatment, 2011, 128(3), 713-723.
   Fulltext  PDF  
 Web of Science® Times Cited: 9

Lie Yang, Birgit Olsson, Daniella Pfeifer, J-I Jönsson, Z-G Zhou, X Jiang, Bengt-Arne Fredriksson, H Zhang and Xiao-Feng Sun
  Knockdown of peroxisome proliferator-activated receptor-beta induces less differentiation and enhances cell-fibronectin adhesion of colon cancer cells
  ONCOGENE, 2010, 29(4), 516-526.
 Web of Science® Times Cited: 11

Gizeh Perez-Tenorio, Elin Karlsson, Marie Ahnström Waltersson, Birgit Olsson, Birgitta Holmlund, Bo Nordenskjöld, Tommy Fornander, Lambert Skoog and Olle Stål
  Clinical Value of RPS6KB1 and RPS6KB2 Gene Amplification in Postmenopausal Breast Cancer
  , 2008, , .

Cecilia Gunnarsson, Piiha-Lotta Jerevall, Karl Hammar, Birgit Olsson, Bo Nordenskjöld, Agneta Jansson and Olle Stål
  Amplification of HSD17B1 has prognostic significance in postmenopausal breast cancer
  Breast Cancer Research and Treatment, 2008, 108(1), 35-41.
 Web of Science® Times Cited: 18

Gizeh Pérez-Tenorio, Liza Alkhori, Birgit Olsson, Marie Ahnstro Waltersson, Bo Nordenskjöld, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
  PIK3CA mutations and PTEN loss correlate with similar prognostic factors and are not mutually exclusive in breast cancer
  Clinical Cancer Research, 2007, 13(12), 3577-3584.
 Web of Science® Times Cited: 120

Marie Stenmark Askmalm, John Carstensen, Bo Nordenskjöld, Birgit Olsson, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
  Mutation and accumulation of p53 related to results of adjuvant therapy of postmenopausal breast cancer patients
  Acta Oncologica, 2004, 43(3), 235-244.
 Web of Science® Times Cited: 13

Olle Stål, Gizeh Perez-Tenorio, Lind Åkerberg, Birgit Olsson, Bo Nordenskjöld, Lambert Skoog and Lars Rutqvist
  Akt kinases in breast cancer and the results of adjuvant therapy
  Breast Cancer Research, 2003, 5(2), R37-R44.
 Web of Science® Times Cited: 98

Cecilia Gunnarsson, Marie Ahnström, Kristina Kirschner, Birgit Olsson, Bo Nordenskjöld, Lars Erik Rutqvist, Lambert Skoog and Olle Stål
  Amplification of HSD17B1 and ERBB2 in primary breast cancer
  Oncogene, 2003, 22(1), 34-40.
 Web of Science® Times Cited: 53

Cecilia Gunnarsson, Birgit Olsson, Olle Stål and Lars-Gunnar Arnesson
  Abnormal expression of 17β-hydroxysteroid dehydrogenases in breast cancer predicts late recurrence
  Cancer Research, 2001, 61(23), 8448-8451.
 Web of Science® Times Cited: 72

Conference Articles

E Karlsson, M A Waltersson, Josefine Bostner, Gizeh Perez-Tenorio, Birgit Olsson, T Fornander and Olle Stål
  Comprehensive Genomic and Transcriptomic Analysis of the 11q13 Amplicon in Breast Cancer in CANCER RESEARCH, vol 69, issue 24, pp 820S-821S
  CANCER RESEARCH, 2009.


* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.